‘Cures’ Plan To Rely On 3rd-Party Audits For Some Device Changes Needs Tweaks, Shuren Says

Reliance upon a third-party assessment of quality systems for certain device modifications might eventually help industry, but it would “probably not” be efficient for FDA’s device center, as proposed in the House 21st Century Cures effort.